Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
27.00
+0.09 (0.33%)
Oct 13, 2026, 3:36 PM EDT - Market open
KMTS Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 |
| 106.73 | 95.13 | 59.82 | 27.81 | 7.63 | - | |
Revenue Growth | 60.72% | 59.03% | 115.05% | 264.54% | - | - |
Cost of Revenue | 49.22 | 46.26 | 35.61 | 27.45 | 18.28 | - |
Gross Profit | 57.51 | 48.86 | 24.21 | 0.36 | -10.65 | - |
Selling, General & Admin | 178.75 | 164.12 | 114.94 | 69.94 | 54.01 | 13.9 |
Research & Development | 22.28 | 19.48 | 15.65 | 15.49 | 15.76 | 18.81 |
Operating Expenses | 201.03 | 183.6 | 130.59 | 85.43 | 69.77 | 32.71 |
Operating Income | -143.52 | -134.74 | -106.38 | -85.06 | -80.42 | -32.71 |
Interest Expense | -7.56 | -7.55 | -7.73 | -6.23 | -5.63 | -1.17 |
Interest & Investment Income | 8.31 | 8.35 | 3.2 | - | - | - |
Other Non Operating Income (Expenses) | -0.48 | 2.62 | -2.77 | -0.09 | 1.83 | -0.04 |
EBT Excluding Unusual Items | -143.26 | -131.32 | -113.68 | -91.38 | -84.22 | -33.91 |
Other Unusual Items | -6.3 | - | - | -2.72 | - | - |
Pretax Income | -149.56 | -131.32 | -113.68 | -94.1 | -84.22 | -33.91 |
Income Tax Expense | 0.31 | 0.29 | 0.14 | 0.02 | 0.02 | 0.19 |
Net Income | -149.87 | -131.61 | -113.81 | -94.12 | -84.24 | -34.1 |
Preferred Dividends & Other Adjustments | - | - | 12.32 | 6.72 | 2.5 | - |
Net Income to Common | -149.87 | -131.61 | -126.14 | -100.84 | -86.74 | -34.1 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 56 | 54 | 25 | 20 | 0 | 0 |
Shares Outstanding (Diluted) | 56 | 54 | 25 | 20 | 0 | 0 |
Shares Change | 72.64% | 120.41% | 23.63% | 18693.84% | - | - |
EPS (Basic) | -2.68 | -2.43 | -5.13 | -5.07 | -819.76 | -322.29 |
EPS (Diluted) | -2.68 | -2.43 | -5.13 | -5.07 | -819.76 | -322.29 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 |
Free Cash Flow | -123.21 | -117.12 | -101.2 | -84.75 | -85.1 | -30.23 |
Free Cash Flow Per Share | -2.20 | -2.16 | -4.12 | -4.26 | -804.32 | -285.72 |
Gross Margin | 53.89% | 51.37% | 40.48% | 1.30% | -139.59% | - |
Operating Margin | -134.47% | -141.65% | -177.84% | -305.83% | -1054.01% | - |
Profit Margin | -140.43% | -138.36% | -210.88% | -362.56% | -1136.79% | - |
Free Cash Flow Margin | -115.44% | -123.12% | -169.19% | -304.70% | -1115.37% | - |
EBITDA | -134.18 | -126.03 | -98.41 | -73.5 | -75.57 | -32.29 |
EBITDA Margin | -125.72% | -132.49% | -164.52% | -264.27% | - | - |
D&A For EBITDA | 9.35 | 8.71 | 7.97 | 11.56 | 4.86 | 0.42 |
EBIT | -143.52 | -134.74 | -106.38 | -85.06 | -80.42 | -32.71 |
EBIT Margin | -134.47% | -141.65% | -177.84% | - | - | - |